期刊:Endocrine Practice [Elsevier BV] 日期:2002-05-01卷期号:8 (3): 222-224被引量:103
标识
DOI:10.4158/ep.8.3.222
摘要
Objective: To present the case of a patient with Graves' hyperthyroidism in whom treatment with methim-azole led to severe cholestasis. Methods: A detailed case report and an overview of previously published cases of methimazole- and carbima-zole-induced hepatotoxicity, found in a MEDLINE search with use of methimazole, carbimazole, thionamides, and antithyroid agents as subject headings, are provided. Results: In a 36-year-old woman with severe hyperthyroidism, treatment with methimazole (20 mg twice daily) was initiated. Nineteen days later, pruritus, scleral icterus, dark urine, and abdominal discomfort prompted discontinuation of the therapy. Laboratory investigations and abdominal ultrasonography showed findings consistent with a cholestatic reaction to methimazole. Recovery was slow but complete. Of the 30 previously published cases of hepatotoxicity related to treatment with methima-zole or carbimazole in which the nature of the hepatic injury was described, 19 were also cholestatic. Conclusion: Ph...